The impact of renal impairment on long-term safety and effectiveness of drug-eluting stents.
Stefanini GG., Taniwaki M., Kalesan B., Räber L., Stortecky S., Pilgrim T., Onuma Y., Silber S., Serruys PW., Meier B., Jüni P., Windecker S.
BACKGROUND: Renal impairment (RI) is associated with impaired prognosis in patients with coronary artery disease. Clinical and angiographic outcomes of patients undergoing percutaneous coronary intervention (PCI) with the use of drug-eluting stents (DES) in this patient population are not well established. METHODS: We pooled individual data for 5,011 patients from 3 trials with the exclusive and unrestricted use of DES (SIRTAX - N = 1,012, LEADERS - N = 1,707, RESOLUTE AC - N = 2,292). Angiographic follow-up was available for 1,544 lesions. Outcomes through 2 years were stratified according to glomerular filtration rate (normal renal function: GFR ≥ 90 ml/min; mild RI: 90